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linked obesity, measured using body mass index (BMI), to clinically relevant measures
of asthma morbidity. This study assessed BMI in a Canadian sample of asthma
outpatients, and evaluated associations between BMI and levels of asthma severity,
asthma control, and asthma-related quality of life.
A total of 382 adult asthma patients underwent demographic and medical history
interviews on the day of their clinic visit. Patients’ self-reported height and weight
were used to calculate BMI (kg/m2). Asthma severity was classified according the
GINA (2002) guidelines. Patients completed the Asthma Control (ACQ) and Asthma
Quality of Life (AQLQ) Questionnaires and underwent standard pulmonary testing
(spirometry).
A total of 139 (36%) patients had a normal BMI; 149 (39%) patients were
overweight; and 94 (25%) patients were obese. There was no relationship between
BMI and asthma severity when controlling for age and sex. Patients with higher BMI
scores had higher ACQ and lower AQLQ scores, independent of age, sex and asthma
severity.Elsevier Ltd. All rights reserved.
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BMI, asthma severity, asthma control and quality of life 649Results identify higher BMI and obesity as potential behavioral factors related to
worse asthma control and quality of life, but not asthma severity, and suggest
important avenues for asthma management and control initiatives.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Despite important advances in diagnosis and treat-
ment, the prevalence of asthma has increased in
recent years in both Canada and the United States.
Asthma currently affects over 8.4% of Canadians1
and 7% of Americans.2 Between 1980 and 1994, the
number of people with asthma increased by over
100%.3 By 1999, over 2.17 million Canadians1 and
nearly 15 million Americans4 had asthma. In 1990,
medical expenditures for asthma-related health
care costs exceeded $6.2 billion in the US5 and $648
million in Canada.6 In 2001, Canadian statistics
showed that only 43% of asthmatics were well
controlled according to Canadian Consensus Guide-
lines.7 This indicates that more than half of all
asthmatics in Canada have poorly controlled or
uncontrolled asthma and are experiencing symp-
toms at a level that interferes with daily activities
and reduces overall quality of life.
In the last 3 decades, the prevalence of obesity
has also risen in both the US and Canada. Recent
(1998) statistics estimate the rate of obesity,
defined as having a body mass index (BMI) of
30 kg/m2 or greater, at over 30% in the US8–10 and
15% in Canada.11 When you also consider those who
may be considered overweight (BMIX25 kg/m2),
these rates as much as triple, reaching 65% of
Americans8 and nearly 50% of Canadians.11 In
absolute numbers, over 11 million Canadians and
130 million Americans are either overweight or
obese, a phenomenon that costs the US healthcare
system an estimated $70 billion dollars per year12,13
and the Canadian healthcare system as much as
$1.8 billion per year.14 The health consequences of
obesity are varied and well established. Obesity has
been shown to either increase risk for or exacer-
bate many serious illnesses including hypertension,
diabetes, arthritis, hypercholesterolemia, coronary
artery disease, restrictive lung disease, sleep
apnea, and cancer.10,13,15
The concurrent rise in asthma and obesity rates
has prompted researchers to investigate associa-
tions between the two disorders. Cross-sectional
studies have found evidence of an association
between asthma and obesity in both children16–18
and adults,19–21 though some have suggested a
more consistent link between asthma and obesity in
women.20,21 Few studies have investigated thetemporal relationship between asthma and obesity,
however, a recent prospective study of 85,911
women found that obesity and increasing BMI was
related to higher rates of new adult-onset asth-
ma.22 Despite evidence that obesity and asthma
tend to co-occur, relatively few studies23–25 have
examined whether BMI is actually associated with
worse asthma severity, or the extent to which
patients with higher BMIs exhibit worse control of
their asthma or worse asthma-related quality of
life. Given recent treatment guidelines emphasiz-
ing improved asthma control and quality of life,26
and the fact that obesity may be considered a
disorder related to poor self-management,27 it
seems important to investigate the potential
impact of increasing BMI on these behaviorally
influenced variables.
The purpose of the present study was threefold:
(1) to estimate the prevalence of overweight and
obesity in a Canadian tertiary care population of
adult asthma patients; (2) to evaluate associations
between BMI and asthma severity; and (3) to
evaluate associations between BMI and levels of
asthma control and asthma-related quality of life.Material and methods
Study participants
Participants were recruited from consecutive pa-
tients presenting to the asthma clinic of Hoˆpital du
Sacre´-Coeur de Montreal from June 2003 to April
2004. This study reflects data collected as part of a
larger study evaluating the prevalence and impact
of psychiatric disorders among adult asthmatics.28
Patients were eligible if they had documented
physician-diagnosed asthma, were between the
ages of 18 and 75, and fluent in English or French.
A total of 990 patients presented to the asthma
clinic, of which 865 (87%) were screened for
inclusion in the study (the remaining 125 had
insufficient medical information with which to
conduct pre-screening). A total of 442 patients
were excluded for failing to meet eligibility criteria
(see Fig. 1), resulting in 423 eligible patients who
were contacted to participate in the study. Only 34
patients declined to participate, which yielded a
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Presented to Clinic
990
Screened for eligibility
865 (87%)
Eligible participants
423 (49%)
Consenting participants
389 (92%)
Final sample
382
Excluded
442 (51%)
- Co-morbid disease = 180
- Unconfirmed asthma =136
- Age criteria =107
Refused to participate
34
Excluded from analyses
7
- Missing data = 6
- BMI > 50 (Kg/m2) = 1
Figure 1 Flow chart of patient screening, eligibility and
participation.
K.L. Lavoie et al.650final sample of 389 patients (92% participation
rate). Six patients were excluded from the analyses
due to incomplete or missing data, and one patient
was excluded for having an outlying BMI of450 kg/
m2, yielding a final sample of 382 patients. This
project was approved by the Ethics Committee of
Hoˆpital du Sacre´-Cœur de Montre´al.Study design
Patients were screened on the day of their asthma
clinic visit to verify eligibility. Asthma diagnosis was
confirmed by chart review and verified by the
treating physician. Participants underwent a demo-
graphic and medical history interview, including
asking patients to report whether a doctor had
diagnosed them with various medical conditions
(e.g., hypertension/high blood pressure; hyperch-
olesterolemia/high cholesterol, and diabetes). Pa-
tients were also asked to report height and weight.
All height and weight variables were converted into
kg and m to calculate BMI. Patients completed the
Asthma Control (ACQ) and Asthma Quality of Life
(AQLQ) Questionnaires and underwent objective
standard pulmonary testing (spirometry) in the
respiratory laboratory as part of their regularphysician visit. Medical information and medication
status and dosage were verified by chart review.
Obesity and asthma severity assessment
BMI (in kg/m2) was calculated from patients’ self-
reported height and weight. Because this study was
part of a larger study that involved extensive and
time-consuming psychological assessments, we
relied upon self-reported height and weight, which
has been shown to be almost identical to and highly
correlated with measured values.25 The interna-
tional standard definition of obesity was used.9,10
Patients were classified as normal if BMI was o25;
overweight if their BMI was X25o30; and obese if
BMI was X30. Only one patient had an excessively
high BMI (X50) and was excluded. Asthma severity
was defined according to the updated 2002 GINA
guidelines26 which categorize asthma severity into
four categories (intermittent, mild persistent,
moderate persistent, and severe persistent).
Asthma control and quality of life assessment
Participants completed the ACQ30 and the AQLQ.31
The ACQ evaluates asthma control by asking
respondents to recall their symptoms and b2-
agonsist use in the last week, plus one question
assessing spirometry results (FEV1, % Pred.). The
ACQ contains 7 items rated on a 7-point scale (0 ¼
good control, 6 ¼ poor control). The AQLQ
evaluates asthma quality of life across four do-
mains: activity limitation, symptoms, emotional
distress, and environmental stimuli. It contains 32
items rated on a 7-point scale (1 ¼ maximal
impairment, 7 ¼ no impairment). Both question-
naires have demonstrated very good measurement
properties, including high intra-class correlation
coefficients between 0.90 and 0.95 and good
construct, cross-sectional and longitudinal valid-
ity,30–33 and have been validated in Quebec
French.34
Pulmonary function testing
All pulmonary testing using standard spirometry
was conducted in the respiratory laboratory by a
trained respiratory technician on the day of the
patient’s clinic visit. Rescue medication was with-
held for at least 4 h before pulmonary function
tests. FEV1 and FVC were assessed before admin-
istration of 200mcg salbutamol using a metered-
dose inhaler or 500 mg terbutaline using a Turbu-
halers. Predicted values of FEV1 and FVC were
calculated from reference values for patients less
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yielding % predicted FEV1 and % predicted FEV1/
FVC.Data analyses strategy
In order to maximize statistical power and due to
the increased potential for bias when categories
(e.g., weight categories) are used in place of
continuous data,37 relationships between BMI (as
a continuous variable) and sociodemographic vari-
ables, medical characteristics, asthma character-
istics, and pulmonary function were analyzed using
general linear models (GLM). The relationship
between BMI and asthma severity was also analyzed
using GLM controlling for age, sex, and asthma
duration. Relationships between BMI and ACQ and
AQLQ scores were analyzed using GLMs controlling
for age, sex, and asthma severity. Though statistics
(F’s) will reflect continuous BMI results, all data is
presented as a function of BMI category (normal,
overweight, obese) in order to more easily inter-
pret the pattern of results. All tests were two-sided
and significance was set at .05. Data analysis was
performed using SAS v8.2 (SAS Institute, Cary NC).Results
Sample characteristics
A total of 382 asthma patients participated in the
present study. Participants were 60% female and
had a mean age of 49 (714.2) years. The mean BMI
for the entire sample was 27 kg/m2 (SD ¼ 5.1). BasedTable 1 Patient demographics and medical characterist
% (n) Normal BMIo25
(n ¼ 139)
Overweigh
BMIX25o
(n ¼ 149)
Age (yr) 47 (15) 49 (14)
Sex (female) 70 (97) 48 (72)
Caucasian 95 (131) 92 (137)
Years of education 13.8 (3.2) 12.9 (3.7)
Employed 62 (83) 66 (98)
Married/cohabitating 61 (81) 70 (104)
Hypertension 17 (23) 19 (28)
Diabetes 2 (3) 5 (8)
Hypercholesterolemia 14 (19) 17 (25)
Ever smoked 46 (63) 54 (81)
Current smoker 15 (21) 8 (12)
Value is M7SD.on the international BMI classification, a total of
139 (36%) patients had a normal BMI; 149 (39%)
patients were overweight; and 94 (25%) patients
were obese.Sociodemographics and comorbid medical
conditions
Sociodemographic characteristics and comorbid
medical conditions presented as a function of BMI
category are presented in Table 1. There were
significant associations between BMI and age
(F ¼ 8:42, Po:01) and BMI and hypertension
(F ¼ 14:67, Po:0001). Patients with a higher BMI
were more likely to be older and have hypertension
than patients with a lower BMI. No other significant
relationships were observed.Asthma characteristics and pulmonary
function
Asthma characteristics and pulmonary function
presented as a function of BMI category are
presented in Table 2. There was a significant
association between BMI and the proportion of
patients taking long-acting bronchodilators
(F ¼ 4:44, P ¼ :04) and a significant negative
relationship between BMI and FVC (F ¼ 6:79,
Po:01). Patients with a higher BMI were more
likely to be taking long-acting bronchodilators and
exhibit a lower FVC during pulmonary function
testing. No other significant relationships were
observed.ics as a function of BMI category.
t
30
Obese BMIX30
(n ¼ 94)
F P
51 (12) 8.42 o.01
68 (64) 0.07 .79
93 (87) 0.19 .66
12.5 (4.3) 2.04 .15
57 (51) 0.01 .91
67 (60) 1.76 .19
30 (28) 14.67 o.0001
9 (8) 3.31 .07
23 (22) 0.54 .46
55 (52) 2.18 .14
13 (12) 1.21 .27
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Table 2 Asthma characteristics and pulmonary function as a function of BMI category.
Normal BMIo25
(n ¼ 139)
Overweight
BMIX25o30
(n ¼ 149)
Obese BMIX30
(n ¼ 94)
F P
Asthma severity, M (SD) 3.2 (.7) 3.2 (.6) 3.3 (.6) 3.60 .06
Asthma duration, yrs, M (SD) 19 (15) 20 (15) 20 (16) 0.86 .35
Atopy, % (n) 65 (89) 64 (95) 63 (59) 0.16 .69
Daily ICS dose M (SD) 641 (549) 703 (547) 799 (558) 3.50 .06
# SAB last week, M (SD) 11 (20) 8 (15) 11 (16) 1.06 .30
SAB, % (n) 98 (135) 97 (144) 99 (93) 0.06 .22
LAB, % (n) 63 (87) 74 (110) 72 (66) 4.44 .03
ICS, % (n) 91 (125) 94 (140) 95 (89) 2.96 .09
Oral CS, % (n) 13 (17) 10 (15) 16 (15) 0.00 .98
Anti-leukotrienes, % (n) 15 (21) 14 (20) 14 (13) 0.14 .71
Anti-Rhinitics, % (n) 17 (23) 24 (35) 20 (18) 0.25 .62
FEV1, % pred. M (SD)
y 79 (20) 79 (21) 75 (19) 2.08 .15
FVC, % pred. M (SD)y 90 (18) 91 (18) 84 (18) 6.79 .01
FEV1/FVC, % pred. M (SD)
y 72 (12) 70 (11) 73 (10) 0.33 .56
ICS ¼ inhaled corticosteroid; SAB ¼ short acting bronchodilator; LAB ¼ long acting bronchodilator; FEV ¼ forced expiratory
volume; FVC ¼ forced vital capacity.
Flucatisone propionate equivalent (mg).
yPre-bronchodilator.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Intermittent Mild Moderate Severe
Normal Overweight Obese
Figure 2 Percentage of patients in each BMI category
presented as a function of asthma severity category.
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Asthma severity presented as a function of BMI
category is presented in Fig. 2. Although there was
a non-significant trend for asthma severity to be
worse with increasing BMI (F ¼ 3:60, P ¼ :06, see
Table 2), when age, sex and asthma duration were
controlled for there was no significant relationship
(F ¼ 1:60, P ¼ :21).BMI sex interaction
Due to previous reports suggesting stronger asso-
ciations between increasing BMI and asthma21,38
and asthma severity39 in women relative to men,
we conducted supplementary GLM analyses of the
interaction between BMI and sex (controlling for
age and asthma duration). The analyses revealed
no significant BMI sex interaction for asthma
severity (F ¼ 0:25, P ¼ :63).Asthma control and quality of life
Scores on the ACQ and AQLQ scales presented as a
function of BMI category are presented in Table 3.
There were significant associations between BMI
and total ACQ score (F ¼ 5:96, Po:01), indicating
that patients with a higher BMI had higher scores on
the ACQ, independent of age, sex, and asthma
severity. There were also significant associations
between BMI and several individual items on the
ACQ. Patients with a higher BMI reported signifi-
cantly greater waking symptoms (F ¼ 3:81, Po:05),
significantly greater limitations in their daily
activities (F ¼ 16:08, Po:001); significantly more
shortness of breath (F ¼ 11:48, Po:001); signifi-
cantly more wheezing (F ¼ 6:76, Po:01); and
significantly greater bronchodilator use (F ¼ 3:64,
Po:05). There was also a significant association
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Table 3 Asthma control and quality of life as a function of BMI category, controlling for age, sex, and asthma
severity.
M (7SEM) Normal BMIo25
(n ¼ 139)
Overweight
BMIX25o30
(n ¼ 149)
Obese BMIX30
(n ¼ 94)
F P
ACQ (total) 1.637.09 1.607.08 1.937.10 5.96 .01
Q 1: Nocturnal waking 1.137.13 0.907.12 1.267.15 1.24 .26
Q 2: Waking symptoms 1.417.13 1.417.12 1.647.15 3.81 .05
Q 3: Activity limitations 1.117.12 1.237.11 1.797.14 16.08 o.001
Q 4: Shortness of breath 1.847.13 1.827.12 2.347.15 11.48 .001
Q 5: Wheezing 1.607.12 1.557.12 2.067.15 6.76 .01
Q 6: Bronchodilator use 1.177.11 1.027.11 1.537.13 3.94 .05
Q 7: % FEV1 2.837.13 2.707.12 2.847.16 0.23 .63
AQLQ (total) 5.187.11 5.177.11 4.847.13 6.30 .01
Symptoms 5.167.12 5.227.11 5.007.14 2.16 .14
Emotions 5.507.12 5.467.12 5.327.15 2.13 .14
Environmental stimuli 5.067.14 4.917.13 4.407.17 13.38 o.001
Activity limitation 5.097.13 5.087.12 4.637.15 8.09 .005
ACQ ¼ Asthma Control Questionnaire; AQLQ ¼ Asthma Quality of Life Questionnaire.
BMI, asthma severity, asthma control and quality of life 653between BMI and total AQLQ score (F ¼ 6:30,
Po:01), indicating that patients with a higher BMI
had lower scores on the AQLQ, independent of age,
sex, and asthma severity. There was also a
significant association between BMI and the envir-
onment subscale (F ¼ 13:38, Po:001) and the
activities subscale (F ¼ 8:09, Po:01) of the AQLQ,
indicating that patients with a higher BMI had worse
asthma-related quality of life by being more
limited in their activities and experiencing greater
symptoms in response to environmental triggers.BMI sex interaction
Controlling for sex in our analyses may have
obscured potential sex differences in the observed
associations between increasing BMI and ACQ and
AQLQ scores. We therefore conducted a series of
GLM’s to assess any potential BMI sex interaction
effects on ACQ and AQLQ scores, controlling for age
and asthma severity. The analyses revealed no
significant BMI sex interactions for total ACQ
score or for any of the individual item scores (all
P’s4.05; see Fig. 3a for scatter plot of total ACQ
scores). However, the analyses did reveal a sig-
nificant pattern of BMI sex interactions for AQLQ
scores, including total AQLQ score (F ¼ 5:78,
Po:05; see Fig. 3b), and for the activity limitation
(F ¼ 8:97, Po:01) and environment (F ¼ 4:02,
Po:05) subscales, indicating that with increasing
BMI, there is a sharper decline in asthma-related
quality of life (including activity limitations and in
relation to environmental triggers) in men com-
pared to women.Discussion
The results of the present study indicate a high rate
of both overweight and obesity among adult
asthmatics seen in a Canadian tertiary care asthma
clinic, and that having a higher BMI is associated
with worse asthma control and quality of life
independent of age, sex and asthma severity. This
suggests that higher BMIs are associated with
clinically relevant asthma morbidity, and that
excess body fat may complicate both asthma
control and quality of life independently of factors
typically related to these variables (i.e., age,
asthma severity). We found no significant associa-
tion between BMI and asthma severity, after
controlling for age and sex. This finding is in
contrast to at least two studies23,25 who did find
significant associations between increasing BMI and
asthma severity. However, our study differed from
these two in at least two important ways: Acker-
man et al.23 failed to control for any potential
confounding variables, which may have at least
partially accounted for their results; and Vassaro
et al.25 measured asthma severity using a compo-
site score rather than an established classification
system (i.e., 1997 NHLBI or 2002 GINA guidelines),
which may also have at least partially accounted
for our discrepant findings.
The present findings did not reveal any significant
sex differences in the relationship between BMI and
asthma severity, which is consistent with the
results of at least two studies.24,40 However, our
findings are contrary to those reported by the
ENFUMOSA Study Group,39 who did observe sex
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Figure 3 (a) Scatter plot of the non-significant BMI sex interaction for total ACQ score. (b) Scatter plot of the
significant BMI sex interaction for total AQLQ score.
K.L. Lavoie et al.654differences in the relationship between BMI and
asthma severity. This may be due to differences in
sampling procedures and/or differences in the way
asthma severity was classified and defined. We
included a consecutive sample of eligible patients,
which may be less subject to selection bias than
convenience sampling that appears to have beenused in the ENFUMOSA study. We also classified
asthma severity according to established criteria
(2002 GINA criteria), which differs from the
ENFUMOSA study who defined severe asthma
according to inhaled corticosteroid treatment
levels and asthma exacerbations in the last year.
Given the potential importance of identifying sex
ARTICLE IN PRESS
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asthma severity, future studies should use consis-
tent definitions of asthma severity in order to
facilitate comparison across studies.
Though we found no sex differences in the
relationship between BMI and asthma control, we
did observe interesting sex differences in BMI–AQLQ
associations, with men experiencing a sharper
decline in asthma-related quality of life compared
to women with increasing BMI. To our knowledge,
this is the first study to report such an association,
and suggests that asthmatic men, rather than
asthmatic women, may be at greater risk of
worsening asthma-related quality of life with
increased body weight. Though this study was not
designed to investigate why such sex differences
may exist, we can speculate as to why they may
have occurred. An examination of the AQLQ
subscales that showed sex differences indicates
that men appear to report worse asthma-related
quality of life on the two subscales (activity
limitation and environmental stimuli) that most
reflect decreases in the functional aspect of quality
of life as a result of asthma. In general, men are
more active than women.41 As such, the loss of
functional capacity with increasing BMI may have
greater meaning for men than women, which may
in part account for our present findings. Future
research is needed to explore these hypotheses.
A total of 64% of this sample of asthma patients
were either overweight or obese, which is nearly
15% more than the national (Canadian) rates of
overweight and obesity.21 Moreover, one out of four
(25%) of asthmatics were considered obese, a rate
that exceeds the national average of 15% by over
two-thirds.11,21 This suggests that obesity may be
more common among adult tertiary care asthmatics
than in the general population, a finding consistent
with studies from other industrialized na-
tions.8,19,42 To our knowledge, this is one of only
two studies to report rates of overweight and
obesity in a Canadian sample of adult asthmatics,
with the other community based study reporting a
similar (though somewhat reduced) rate of obesity
(20%).21 Taken together, these studies indicate a
robust relationship between BMI and asthma in both
community and tertiary care settings in Canada.
Previous reports have linked either higher BMI or
obesity to increased prevalence of asthma symp-
toms such as wheezing43–45 and shortness of
breath.44,45 The present study strengthens this
data by assessing a range of asthma symptomatol-
ogy, including measures of symptoms, medication
use, and functional status, and demonstrating
these associations independent of disease severity.
The AQLQ data also reveals a pattern consistentwith greater functional impairment in asthma
patients with higher BMIs, both in terms of being
more limited in their activities and experiencing
greater symptoms in response to environmental
triggers. Though our findings reveal a potentially
stronger BMI–AQLQ relationship in men, our main
analyses revealed significant BMI–AQLQ associations
independent of sex. Although it may be argued that
patients with higher BMIs may be more restricted in
their daily activities due to their excess weight,
there are at least two points which make this
conclusion unlikely. First, patients are specifically
questioned about activity limitations due to their
asthma. Second, the relationships observed are
between BMI in its continuous form, and each
variable of interest. As such, the relationship
between activity limitation and BMI is true even
for patients who fall within the normal range of
BMI, but who have a relatively higher BMI than
others in their category. Therefore, having a higher
BMI is associated with greater activity limitation in
patients at all levels of BMI categories and for those
who may not necessarily be obese.
Though this study was not designed to evaluate
why asthmatics with increasing BMI may have worse
asthma control and asthma-related quality of life,
we can hypothesize as to why these associations
were observed. It is known that obese patients tend
to experience wheezing and breathlessness due to
their excess weight.45,46 It is therefore possible
that obese patients may have falsely attributed
weight-related respiratory symptoms to asthma,
causing increased use of their bronchodilator.44
However, the fact we found evidence of worse
asthma control across the entire range of BMI (and
not exclusively in patients who were obese) makes
this explanation unlikely. Thompson et al.24 also
reported no evidence of less ‘‘real’’ asthma in
obese versus non-obese asthmatics, and is consis-
tent with our findings of comparable pulmonary
function (i.e., FEV1, FEV1/FVC, % predicted) (with
the exception of FVC which likely reflects mechan-
ical limitations in VC), across all levels of BMI.
Given that being overweight or obese suggests
chronic difficulties with self-management of diet
and exercise behavior, an alternative explanation
may be that asthmatics with increasing BMI may
have worse asthma control due to behavioral
factors associated with poor asthma self-manage-
ment. There is evidence to suggest that increases in
BMI are associated with both delay and avoidance
of health care seeking behavior,47 which may have
implications for symptom monitoring and ensuring
adequate symptom control. If optimal asthma
control depends on regular contact with treat-
ing physicians, targeting overweight and obese
ARTICLE IN PRESS
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bly healthcare workers to improve attitudes to-
wards overweight and obese patients, represent
important goals for clinical research. There are
encouraging results from at least two studies
showing improvements in respiratory function,
airway obstruction, and peak expiratory flow
variability following weight reduction in obese
patients with asthma.48,49 Future studies examining
the effects of weight loss on asthma should include
measures of asthma control and functional capacity
(quality of life) to determine whether weight loss
interventions can also impact behavioral variables.
There are some limitations to the present study.
One involves the use of self-reported height and
weight for the calculation of BMI. However, data
from the National Health and Nutrition Examination
Survey (NHANES-III) found that self-reported height
and weight does not differ substantially from
measured values.29 In fact, BMI values derived from
measured and self-reported height and weight are
highly correlated (r ¼ 0:8920:97, P’so.001).25
Moreover, the sensitivity and specificity of self-
reported to predict measured values of height and
weight are excellent for adults under the age of 80,
ranging from 86–94% (sensitivity) to 96–99% (speci-
ficity), with a tendency for self-reported measures
to be underestimates. As we excluded patients over
the age of 75, we are quite confident in our
estimates of BMI. Another potential limitation of
this study involves the nature of the population we
studied. We sampled asthmatics followed at a
tertiary care hospital whose asthma may be some-
what more severe than patients followed by primary
care physicians or community samples. Therefore,
results may not generalize to non-tertiary-care
asthma patients. We also did not assess hormonal
variables which may be important mediators of
BMI–asthma relationships in women.25 Finally, we
restricted our measures of excess body weight to
BMI, however other measures, such as central
adiposity or abdominal obesity,50,51 may also be
important. Future studies assessing the impact of
increasing body fat on asthma should include a
broader range of measures such as waist–hip ratio,
waist/abdominal circumference, and direct mea-
sures of total body fat in order to determine the
relative importance of each measure.
In conclusion, our findings suggest that higher BMI
may have important implications for asthma symp-
toms, medication use, and functional impairment,
and that men may experience a sharper decline in
asthma-related quality of life with increasing BMI.
Though previous studies have found associations
between obesity and increased asthma symptoma-
tology, no study has specifically evaluated whetherasthmatics with higher BMIs demonstrate worse
asthma control and quality of life irrespective of
BMI ‘‘category’’. Results suggest that patients need
not be classified as ‘‘obese’’ for excess weight and
body fat to compromise several important asthma
variables. Findings identify BMI and obesity as
important behavioral factors in asthma control
and suggest important avenues for asthma manage-
ment and control initiatives. Though there is
evidence of improved lung function following
weight reduction in obese asthmatics, future
studies should assess a broader range of body
weight measures and include measures of asthma
control and quality of life to determine whether
weight loss interventions can impact multiple
measures of body weight as well as behavioral
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